Consegna Group (ASX: CGP) has received a price and volume query from the ASX over a 57% share price jump to a high of A$0.052 today, a day when the overall market is down 1%, up from a close of $0.033 on Friday 30 December 2011.
The company responded to the ASX saying it is not aware of any material information that has not been disclosed to the market, which may explain the sudden investor interest.
Consegna did, however, make mention of the fact its products have received “significant print and television media attention over the previous weeks”.
In December, Consegna Group announced the closing of the purchase of Aspen Medisys, LLC. Aspen's portfolio includes a nanoparticle magnetic thermotherapy technology platform for the treatment of solid tumours.
Prior to that, in late November, Consegna announced it was ready to start negotiating licences for the commercialisation of its BreatheAssist device.
BreatheAssist is a multi-functional nasal dilation technology that enhanced nasal airflow by 37% in a clinical study.
Importantly, there are multiple licensing opportunities for BreatheAssist, including sport, medication delivery, snoring cessation, aiding sleep apnoea and the filtration of pollen and other airborne pollutants.
Originally published at: http://www.proactiveinvestors.com.au/companies/news/23840/consegna-group-attracts-investor-interest-and-an-asx-speeding-ticket-for-57-share-price-rally--23840.html
Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.
No comments:
Post a Comment